MENU

Movement Disorders

The Latest
More in Movement Disorders

News

06.16.20

Risdiplam Improves Motor Symptoms in Spinal Muscular Atrophy
  • KEYWORDS:
  • Movement disorders
  • Risdiplam
  • Spinal muscular atrophy
Clinical Trials for Huntington Disease image

Special Report

Clinical Trials for Huntington Disease

The promise for potential disease-modifying research is strong, although continued discovery uncovers new questions and challenges to overcome.

Natalia P. Rocha, PharmD, MSc, PhD; Gabriela D. Colpo, PhD; Antonio L. Teixeira, MD, PhD, MSc; and Erin Furr Stimming, MD

Teleneurology Billing and Coding image

Cover Focus

Teleneurology Billing and Coding

Perspectives on coding evaluation & management during the COVID-19 pandemic.

Brad Klein, MD, MBA, FAAN, FAHS, FAANEM, and Raissa Villanueva MD, MPH, FAAN

Teleneuro-ophthalmology image

Cover Focus

Teleneuro-ophthalmology

Something can almost always be offered virtually for people with neuro-ophthalmologic conditions.

Melissa W. Ko, MD; Kevin E. Lai, MD; and Devin D. Mackay, MD

News

05.28.20

Istradefylline Reduces OFF Time and Symptoms in Parkinson Disease
  • KEYWORDS:
  • Dyskinesia
  • Istradefylline
  • Movement disorders
  • Parkinson disease

News

05.21.20

FDA Approves Apomorphine Sublingual Film for Treatment of OFF Periods in Parkinson Disease
  • KEYWORDS:
  • Apomorphine
  • Apomorphine sublingual film
  • FDA Approvals
  • Parkinson disease

News

05.04.20

New Podcast on COVID-19 Pandemic for People With Parkinson Disease 
  • KEYWORDS:
  • Coronavirus
  • COVID-19
  • Movement disorders
  • Parkinson disease
Movement Disorders Moment: Medicinal Marijuana for Movement Disorders image

Columns

Movement Disorders Moment: Medicinal Marijuana for Movement Disorders

Update on clinical use of medical marijuana for movement disorders.

Lee I. Kubersky, MD

News

04.30.20

Higher Rates of COVID-19 Infection and Death for People With Parkinson Disease 
  • KEYWORDS:
  • Ageusia
  • Anosmia
  • COVID-19
  • Parkinson disease

News

04.27.20

FDA Approves Opicapone as Adjunctive to Levodopa for Parkinson Disease 
  • KEYWORDS:
  • Movement disorders
  • opicapone
  • Parkinson disease

News

04.02.20

Study Shows Teletherapy Is Effective for Depression in Individuals with Parkinson Disease
  • KEYWORDS:
  • Cognitive therapy
  • Major depressive disorder
  • Movement disorders
  • Parkinson disease

News

03.18.20

FDA Grants Fast Track Designation to Verdiperstat for MSA Treatment
  • KEYWORDS:
  • Multiple system atrophy
  • verdiperstat
Medical Transition from Pediatric to Adult Care in Neurology image

Cover Focus

Medical Transition from Pediatric to Adult Care in Neurology

It is critical to see transition as a process not simply a moment in time when care is transferred.

Lawrence W. Brown, MD

Comprehensive Behavioral Intervention for Tics image

Cover Focus

Comprehensive Behavioral Intervention for Tics

A practical review for clinicians.

Carinna M. Scotti-Degnan, PhD, and Hannah A. Ford, PhD

Show More